info@healthcostinstitute.org

mediA@healthcostinstitute.org

  • X
  • LinkedIn
  • Link
Search
Health Care Cost Institute
  • Home
  • About US
    • HCCI Data
    • HCCI Staff
      • CEO
      • Careers
    • Financial Statements
    • Governing Board 
  • Data Tools
    • Data Access Hub
    • HCCI Vitals
    • Healthprices.org
    • HMI
    • DataNerd
  • Research
    • Original Reports
    • HCCUR
    • Vitals HMI
Search

External Research

  • AJPM: Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use

    AJPM: Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use
    Yuhua Bao, Hao Zhang, Katherine Wen, Phyllis Johnson, Philip Jeng, Lisa Witkin, Sean Nicholson, M Carrington Reid, Bruce Shackman
    July 4, 2021

     Introduction This study assesses the associations between the recent implementation of robust features of state Prescription Drug Monitoring Programs and the abrupt discontinuation of long-term opioid therapies. Methods Data were from a national commercial insurance database and included privately insured adults aged 18–64 years and Medicare Advantage enrollees aged ≥65 years who initiated a long-term…

    Read more: AJPM: Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • AJMC: Commercial and Medicare Advantage Payment for Anesthesiology Services

    AJMC: Commercial and Medicare Advantage Payment for Anesthesiology Services
    Erin L. Duffy, Bich Ly, Loren Adler, and Erin Trish
    June 24, 2021

     ABSTRACT Objectives: Anesthesiology services are a focal point of policy making to address surprise medical billing. However, allowed amounts and charges for anesthesiology services have been understudied due to the specialty’s unique conversion factor (CF) unit of payment and complex provider structures involving anesthesiologists and certified registered nurse anesthetists (CRNAs). This study compares payments for…

    Read more: AJMC: Commercial and Medicare Advantage Payment for Anesthesiology Services
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • AJMC: Association Between Hospital-Insurer Contract Structure and Hospital Performance

    AJMC: Association Between Hospital-Insurer Contract Structure and Hospital Performance
    Eric Barrette, Christopher Garmon, Kevin Kennedy
    June 15, 2021

    ABSTRACT Objectives: To describe the association between the form of hospitals’ contracts—either markup from a benchmark or a discount from a list price—and performance: price, charge, cost, and length of stay. Study Design: Retrospective observational study using administrative claims data matched with hospital characteristics from the American Hospital Association Annual Survey and the Healthcare Cost…

    Read more: AJMC: Association Between Hospital-Insurer Contract Structure and Hospital Performance
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • JAMA Network: Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis

    JAMA Network: Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis
    Hao Zhang, Austin S. Kilaru, Zachary F. Meisel, Yuhua Bao,
    June 14, 2021

    Abstract: Patients with sickle cell disease (SCD) or cancer with bone metastasis often present to the emergency department (ED) for treatment of severe pain, and opioid analgesics remain first-line therapies for acute pain in the ED or after discharge. Policies aimed at improving the safety of opioid prescribing, such as state legislative mandates that prescribers register with or…

    Read more: JAMA Network: Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • JAMA Health Forum: Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps

    Tags: Spending
    JAMA Health Forum: Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
    Stacie Dusetzina, Haiden Huskamp, and Shelley Jazowski
    May 28, 2021

    Abstract:  IMPORTANCE  By 2020, nearly all states had adopted oncology parity laws in the US, ensuring that patients in fully insured private health plans pay no more for orally administered anticancer medications (OAMs) than infused therapies. Between 2013 and mid-2017, 11 states implemented parity with out-of-pocket spending caps, which may further reduce patient out-of-pocket spending….

    Read more: JAMA Health Forum: Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • NYS Health Foundation: Variation in Health Care Prices: The Problem Starts at Birth

    Tags: Maternal Health
    NYS Health Foundation: Variation in Health Care Prices: The Problem Starts at Birth
    New York State Health Foundation
    May 11, 2021

    Summary The price of childbirth in New York City varies multifold, depending on where a woman delivers. This variation in price across boroughs, and across providers within boroughs, might make sense if it corresponded to higher-quality care. But higher prices do not always signify better quality. This report examines variation in what is paid for…

    Read more: NYS Health Foundation: Variation in Health Care Prices: The Problem Starts at Birth
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • Health Affairs: Private Equity In Dermatology: Effect On Price, Utilization, And Spending

    Health Affairs: Private Equity In Dermatology: Effect On Price, Utilization, And Spending
    Robert Tyler Braun, Amelia M. Bond, Yuting Qian, Manyao Zhang, Lawrence Casalino
    May 5, 2021

    Abstract: Private equity firms have increasingly acquired physician practices, and particularly dermatology practices. Analyzing commercial claims from the Health Care Cost Institute (2012–17), we used a difference-in-differences design within an event study framework to estimate the prevalence of private equity acquisitions and their impact on dermatologist prices, spending, utilization, and volume of patients. By 2017…

    Read more: Health Affairs: Private Equity In Dermatology: Effect On Price, Utilization, And Spending
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • American Economic Review: Screening and Selection: The Case of Mammograms

    Tags: Mammograms
    American Economic Review: Screening and Selection: The Case of Mammograms
    Liran Einav, Amy Finkelstein, Tamar Oostrom, Abigail Ostriker, and Heidi Williams
    December 21, 2020

    Abstract: We analyze selection into screening in the context of recommendations that breast cancer screening start at age 40. Combining medical claims with a clinical oncology model, we document that compliers with the recommendation are less likely to have cancer than younger women who select into screening or women who never screen. We show this…

    Read more: American Economic Review: Screening and Selection: The Case of Mammograms
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • American Journal of Managed Care: Policies to Address Surprise Billing Can Affect Health Insurance Premiums

    Tags: Commercially Insured, Surprise Billing
    American Journal of Managed Care: Policies to Address Surprise Billing Can Affect Health Insurance Premiums
    Erin L. Duffy, Bich Ly, Loren Adler, Erin Trish
    September 11, 2020

     Abstract:  Objectives: To quantify the proportion of health plan spending on services for which surprise billing is common—provided by radiologists, anesthesiologists, pathologists, emergency physicians, emergency ground ambulances, and emergency outpatient facilities—and estimate the potential impact of proposed policies to address surprise billing on health insurance premiums. Study Design: Analysis of 2017 commercial claims data from…

    Read more: American Journal of Managed Care: Policies to Address Surprise Billing Can Affect Health Insurance Premiums
    • Facebook
    • X
    • LinkedIn
    • Pinterest
  • PNAS: Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reform

    Tags: Medicare Advantage, Peer Reviewed Journals, PNAS
    PNAS: Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reform
    Liran Einav, Amy Finkelstein, Yunan Ji, Neale Mahoney
    July 27, 2020

    Abstract:  Changes in the way health insurers pay healthcare providers may not only directly affect the insurer’s patients but may also affect patients covered by other insurers. We provide evidence of such spillovers in the context of a nationwide Medicare bundled payment reform that was implemented in some areas of the country but not in others,…

    Read more: PNAS: Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reform
    • Facebook
    • X
    • LinkedIn
    • Pinterest
«
1 2 3 4 … 7
»

Enhance your research using customized data analysis

Are you interested in a specific health care topic? HCCI can use our commercial and government data resources and unique analytic experience to help you. Just reach out!

Partner with us

About

We are a mission-driven, independent, nonprofit organization situated at the nexus of data, analytics, and action.

Contact

1100 G Street NW, Suite 600
Washington DC, 20005

info@healthcostinstitute.org
media@healthcostinstitute.org

Research

HCCI Publications
Research Resources

Data

Data Access Hub
Data Tools

Quick Links

Partner with HCCI
HCCI Newsletter
Careers

  • LinkedIn
  • X
  • Link
  • Bluesky

© 2025 Health Care Cost Institute Inc.
Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License

Scroll to Top